These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23173569)

  • 1. Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan.
    Chang PY; Lee CM; Hsu HC; Lin HJ; Chien KL; Chen MF; Chen CH; Lee YT; Yang CY
    Lipids Health Dis; 2012 Nov; 11():162. PubMed ID: 23173569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.
    van Capelleveen JC; Lee SR; Verbeek R; Kastelein JJP; Wareham NJ; Stroes ESG; Hovingh GK; Khaw KT; Boekholdt SM; Witztum JL; Tsimikas S
    J Clin Lipidol; 2018; 12(6):1493-1501.e11. PubMed ID: 30249512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
    Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
    Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.
    Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B
    Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia.
    Wang J; Kockx M; Bolek M; Lambert T; Sullivan D; Chow V; Kritharides L
    J Lipid Res; 2024 Jul; 65(7):100577. PubMed ID: 38879166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
    Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it.
    Xiong X; Liu H; Hua L; Zhao H; Wang D; Li Y
    Lipids Health Dis; 2015 Oct; 14():127. PubMed ID: 26452348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation between apolipoprotein CIII gene polymorphism and coronary artery disease].
    Liu SK; Mu X; Yang YY; Xu Q; Wang XM; Ding RJ; Zhang ZC
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1133-5. PubMed ID: 17672999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.
    Hopkins PN; Nanjee MN; Wu LL; McGinty MG; Brinton EA; Hunt SC; Anderson JL
    Atherosclerosis; 2009 Dec; 207(2):559-66. PubMed ID: 19524242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
    Luo M; Liu A; Wang S; Wang T; Hu D; Wu S; Peng D
    Sci Rep; 2017 May; 7(1):2312. PubMed ID: 28539597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
    Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.